Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCT.

Collinson F, Royle KL, Swain J, Ralph C, Maraveyas A, Eisen T, Nathan P, Jones R, Meads D, Min Wah T, Martin A, Bestall J, Kelly-Morland C, Linsley C, Oughton J, Chan K, Theodoulou E, Arias-Pinilla G, Kwan A, Daverede L, Handforth C, Trainor S, Salawu A, McCabe C, Goh V, Buckley D, Hewison J, Gregory W, Selby P, Brown J, Brown J, all the STAR investigators

Open source

DOI
10.3310/jwtr4127
Published
2024 Aug
Container
Health technology assessment (Winchester, England)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3310/jwtr4127,
  title = {Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCT.},
  author = {Collinson F and Royle KL and Swain J and Ralph C and Maraveyas A and Eisen T and Nathan P and Jones R and Meads D and Min Wah T and Martin A and Bestall J and Kelly-Morland C and Linsley C and Oughton J and Chan K and Theodoulou E and Arias-Pinilla G and Kwan A and Daverede L and Handforth C and Trainor S and Salawu A and McCabe C and Goh V and Buckley D and Hewison J and Gregory W and Selby P and Brown J and Brown J and all the STAR investigators},
  year = {2024},
  journal = {Health technology assessment (Winchester, England)},
  doi = {10.3310/jwtr4127},
  url = {https://doi.org/10.3310/jwtr4127}
}

RIS

TY  - JOUR
TI  - Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCT.
AU  - Collinson F
AU  - Royle KL
AU  - Swain J
AU  - Ralph C
AU  - Maraveyas A
AU  - Eisen T
AU  - Nathan P
AU  - Jones R
AU  - Meads D
AU  - Min Wah T
AU  - Martin A
AU  - Bestall J
AU  - Kelly-Morland C
AU  - Linsley C
AU  - Oughton J
AU  - Chan K
AU  - Theodoulou E
AU  - Arias-Pinilla G
AU  - Kwan A
AU  - Daverede L
AU  - Handforth C
AU  - Trainor S
AU  - Salawu A
AU  - McCabe C
AU  - Goh V
AU  - Buckley D
AU  - Hewison J
AU  - Gregory W
AU  - Selby P
AU  - Brown J
AU  - Brown J
AU  - all the STAR investigators
PY  - 2024
JO  - Health technology assessment (Winchester, England)
DO  - 10.3310/jwtr4127
UR  - https://doi.org/10.3310/jwtr4127
ER  - 

APA

F, C., KL, R., J, S., C, R., A, M., T, E., P, N., R, J., D, M., T, M. W., A, M., J, B., C, K., C, L., J, O., K, C., E, T., G, A., A, K., L, D., C, H., S, T., A, S., C, M., V, G., D, B., J, H., W, G., P, S., J, B., J, B., & investigators, A. T. S. (2024). Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCT.. Health technology assessment (Winchester, England). https://doi.org/10.3310/jwtr4127

Source records